News & Views

  • Partnership begins Validation Process for COVID-19 Diagnostic Test
    Joe Fitchett

Partnership begins Validation Process for COVID-19 Diagnostic Test

Mar 26 2020 Read 282 Times

Following the earlier announcement of circa £1 million funding (1) for development of a diagnostic test for Coronavirus (COVID-19), Mologic has initiated early validation of COVID-19 point-of-need diagnostic tests with the Liverpool School of Tropical Medicine and St Georges’ University London, (March 26)

The accelerated development of the test was made possible by funding from UK Aid, as part of the £46 million the UK government has announced so far for international coronavirus (COVID-19) prevention and research.

Following rapid assessments in the UK, the technology will be shipped to global validation partners including the Institut Pasteur de Dakar in Senegal, La Jolla Institute for Immunology in the United States, the Wuhan Institute of Virology in China, the University of Malaya in Malaysia, the Institute for Health Science Research Germans Trias I Pujol (IGTP) in Spain, and the Oswaldo Cruz Foundation (Fiocruz) in Brazil.

Once ready, the device will allow users to test for exposure to the virus at home, in the community, or in the clinic, providing a result within 10 minutes, without the need for special training, electricity or a laboratory. The company is working in close partnership with the Institut Pasteur de Dakar to validate the COVID-19 test and manufacture at diaTROPiX, a new facility in Senegal. It will be sold to at cost to low-income settings to ensure affected countries have access to the kits during the global emergency. 

Professor Paul Davis, Co-Founder and Chief Scientific Officer, Mologic, commented: “Completion of the first prototypes is a significant step in Mologic’s development of a rapid diagnostic test for COVID-19 and we are proud of our team’s achievement in reaching this point so quickly, while maintaining the most rigorous standards. Diagnostics are a critical weapon in the fight against this pandemic and, once ready, this test will enable affordable, more accurate and earlier diagnosis of infection, limiting the spread of the disease.”

 Dr Joe Fitchett, Medical Director, Mologic, said: “Until a vaccine is ready or a medicine is proven to be effective, we need to decentralise diagnostics to the community as quickly as possible. Properly assessing new tests during an epidemic is a critical and necessary step to ensuring access to the technology. Mologic’s prototypes will now be subject to international validation, with leading labs across the world.”

International Development Secretary Anne-Marie Trevelyan, said: “The UK has been at the heart of the global response to the coronavirus outbreak, investing heavily in the research and development of potential new tests and vaccines, including the work of world-class scientists across the UK. It is enormously encouraging to see the progress the British based lab Mologic, funded by UK aid, has already made to develop a reliable test for the virus, for use in the UK and around the world.”

Dr Emily Adams, Senior Lecturer in Diagnostics for Infectious Disease, Liverpool School of Tropical Medicine, commented: “We are extremely pleased to be working alongside Mologic and diaTROPiX on the evaluation and validation of rapid diagnostic tests for COVID-19. These tests could be a game changer for diagnosis and follow-up of patients both in hospital and in the community, allowing us to detect cases early and isolate patients and their families rapidly. Of course in low-resource settings, where we are starting to see cases, these are the only tests that are appropriate for use. We need to manufacture and deliver as soon as we possibly can.”

(1) Funded by the Wellcome Trust and the Department for International Development (DFID)see www labmate-online March

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment




Digital Edition

Labmate UK & Ireland March 2020

March 2020

In This Edition Articles - Meet. Learn. Discover - Ways to tackle the spread of coronavirus using viricidal surface decontamination Features Chromatography - New Wettable Phase Thri...

View all digital editions

Events

MSACL 2020 US - EVENT CANCELLED

Mar 29 2020 Palm Springs, CA, USA

North Africa Health - EVENT POSTPONED

Apr 07 2020 Cairo, Egypt

FORUMESURE

Apr 13 2020 Casablanca, Morocco

AOCS Annual Meeting & Expo - EVENT CANCELLED

Apr 26 2020 Montreal, Quebec, Canada

View all events